PACE4-altCT being overexpressed in PCa tumors (Fig. 2B and previous work)6, we sought to investigate its presence in plasma from patients through the use of an ELISA assay to detect both total PACE4 levels as well as PACE4-altCT levels. The gene discussed is PCSK6; the disease is posterior cortical atrophy.